CCL25/CCR9 Interactions Regulate Large Intestinal Inflammation in a Murine Model of Acute Colitis
2011

CCR9 Regulates Large Intestinal Inflammation

Sample size: 78 publication 10 minutes Evidence: high

Author Information

Author(s): Wurbel Marc-Andre, McIntire Maria G., Dwyer Peter, Fiebiger Edda

Primary Institution: Children's Hospital Boston, Harvard Medical School

Hypothesis

Do CCL25/CCR9 interactions play a role in the regulation of inflammatory responses in the large intestine?

Conclusion

CCL25/CCR9 interactions regulate inflammatory immune responses in the large intestinal mucosa by balancing different subsets of dendritic cells.

Supporting Evidence

  • CCR9−/− mice showed increased mortality and delayed recovery during DSS-mediated colitis.
  • CCL25 and CCR9 are both expressed in the large intestine and are upregulated during DSS colitis.
  • During recovery, CCR9−/− colonic mucosa is characterized by the accumulation of activated macrophages and elevated levels of inflammatory cytokines.

Takeaway

This study shows that a specific interaction between two proteins helps control inflammation in the intestines, and without it, mice get sicker.

Methodology

The study used a murine model of DSS-induced colitis to assess inflammation and recovery in wild-type and CCR9−/− mice, analyzing cytokine levels and immune cell populations.

Potential Biases

Potential bias in the interpretation of results due to the use of a single animal model.

Limitations

The study is limited to a murine model and may not fully translate to human conditions.

Participant Demographics

Mice used in the study included wild-type and genetically modified strains.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016442

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication